| 1 |
33520371 | Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells. | 2021 |
2 |
| 2 |
34200450 | Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling. | 2021 Jun 7 |
1 |
| 3 |
31825565 | Molecular Epitope Determination of Aptamer Complexes of the Multidomain Protein C-Met by Proteolytic Affinity-Mass Spectrometry. | 2020 Feb 17 |
1 |
| 4 |
31881189 | Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met. | 2020 Feb 15 |
1 |
| 5 |
31973231 | Novel Peptide CM 7 Targeted c-Met with Antitumor Activity. | 2020 Jan 21 |
3 |
| 6 |
32028611 | New Preclinical Development of a c-Met Inhibitor and Its Combined Anti-Tumor Effect in c-Met-Amplified NSCLC. | 2020 Feb 3 |
1 |
| 7 |
32070026 | Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET. | 2020 Feb 13 |
1 |
| 8 |
30692572 | Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures. | 2019 Jan 28 |
1 |
| 9 |
30909596 | New Phosphorylation Sites of Rad51 by c-Met Modulates Presynaptic Filament Stability. | 2019 Mar 23 |
1 |
| 10 |
31584260 | Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma. | 2019 Oct 16 |
2 |
| 11 |
31832192 | Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer. | 2019 |
1 |
| 12 |
31867280 | Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer. | 2019 |
1 |
| 13 |
30309648 | Disproportionately high levels of HGF induce the degradation of the c-met receptor through the proteasomal degradation pathway. | 2018 Nov 2 |
1 |
| 14 |
30466782 | Prolonged MEK inhibition leads to acquired resistance and increased invasiveness in KRAS mutant gastric cancer. | 2018 Dec 9 |
2 |
| 15 |
31949583 | Immunostaining by dual tumor tissue paraffin blocks increases the sensitivity of c-Met detection in gastric cancer. | 2018 |
1 |
| 16 |
28179995 | Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling. | 2017 |
1 |
| 17 |
27773821 | Tyrosine phosphorylation of RalGDS by c-Met receptor blocks its interaction with Ras. | 2016 Nov 18 |
2 |
| 18 |
24362531 | Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. | 2015 Jan 8 |
1 |
| 19 |
24634221 | Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells. | 2014 May 9 |
4 |
| 20 |
22996389 | Dissociation of c-Met phosphotyrosine sites in human cells in response to mouse hepatocyte growth factor but not human hepatocyte growth factor: the possible roles of different amino acids in different species. | 2013 Jun |
2 |
| 21 |
23288161 | Rhodocetin-αβ-induced neuropilin-1-cMet association triggers restructuring of matrix contacts in endothelial cells. | 2013 Mar |
1 |
| 22 |
23624790 | Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function. | 2013 Jul 1 |
5 |
| 23 |
23952536 | Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment. | 2013 Nov |
1 |
| 24 |
23968581 | 3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells. | 2013 Nov |
1 |
| 25 |
24081687 | Herbacetin, a constituent of ephedrae herba, suppresses the HGF-induced motility of human breast cancer MDA-MB-231 cells by inhibiting c-Met and Akt phosphorylation. | 2013 Nov |
1 |
| 26 |
21163258 | An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding. | 2011 Jan 21 |
2 |
| 27 |
21283737 | Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay. | 2011 Jan 21 |
6 |
| 28 |
21316260 | Targeting phosphoinositide 3-kinase signalling in lung cancer. | 2011 Nov |
1 |
| 29 |
21423210 | HGF-independent potentiation of EGFR action by c-Met. | 2011 Aug 18 |
1 |
| 30 |
21734462 | c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition. | 2011 Sep 15 |
1 |
| 31 |
21777671 | Intracellular signaling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A. | 2011 Dec |
2 |
| 32 |
20432459 | Involvement of receptor tyrosine phosphatase DEP-1 mediated PI3K-cofilin signaling pathway in sorafenib-induced cytoskeletal rearrangement in hepatoma cells. | 2010 Aug |
1 |
| 33 |
20551596 | The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. | 2010 |
1 |
| 34 |
20623641 | The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. | 2010 Aug |
1 |
| 35 |
19121849 | Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin. | 2009 Apr |
2 |
| 36 |
19375427 | A bioactive drug quantitation based approach for the detection of anti-drug neutralizing antibodies in human serum. | 2009 Jun 30 |
1 |
| 37 |
19403923 | Development of a cell-based assay for measurement of c-Met phosphorylation using AlphaScreen technology and high-content imaging analysis. | 2009 Apr |
1 |
| 38 |
19240370 | Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer. | 2008 |
1 |
| 39 |
17689859 | CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression. | 2007 Nov 8 |
1 |
| 40 |
17689924 | Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin. | 2007 Nov |
1 |
| 41 |
18046719 | Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5. | 2007 Dec |
2 |
| 42 |
16291834 | hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. | 2006 Jan |
1 |
| 43 |
16415345 | Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase. | 2006 Mar 31 |
6 |
| 44 |
16724983 | Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death. | 2006 Jun |
1 |
| 45 |
17062641 | Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells. | 2006 Nov 15 |
1 |
| 46 |
15839837 | Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. | 2005 Aug 15 |
1 |
| 47 |
16227408 | Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. | 2005 Oct |
1 |
| 48 |
16237757 | Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. | 2005 Sep 28 |
2 |
| 49 |
15075332 | Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. | 2004 Jun 18 |
3 |
| 50 |
15187417 | Enhancement of hepatocyte growth factor-induced cell scattering in N-acetylglucosaminyltransferase III-transfected HepG2 cells. | 2004 Jun |
1 |